Stroke rehabilitation. 1. Epidemiologic aspects and acute management (Q33634868)

28 July 2017

1 reference

title

Stroke rehabilitation. 1. Epidemiologic aspects and acute management (English)

1 reference

28 July 2017

D G Stewart

1 reference

28 July 2017

language of work or name

1 reference

1 May 1999

1 reference

Archives of Physical Medicine and Rehabilitation

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

issue

5 Suppl 1

1 reference

28 July 2017

page(s)

S4-7

1 reference

28 July 2017

cites work

Epidemiology of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Clinical epidemiology of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

African Americans and women have the highest stroke mortality in Texas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Correlation of xenon-enhanced computed tomography-defined cerebral blood flow reactivity and collateral flow patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Brain edema after stroke. Clinical syndrome and intracranial pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Selective gene expression in focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Effects of public and professional education on reducing the delay in presentation and referral of stroke patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

An analysis of time of presentation after stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Tissue plasminogen activator for acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Thrombolytic therapy with streptokinase in acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Tissue-type plasminogen activator should not be used in acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Neuroprotection as Initial Therapy in Acute Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Transesophageal echocardiographic findings in stroke subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

Clinical and ultrasonic long-term results of percutaneous transluminal carotid angioplasty. A prospective follow-up of 30 carotid angioplasties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2899%2990095-3

10.1016/S0003-9993(99)90095-3

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference